Become A Featured Company

Canadian Cannabis Corp. to Acquire Controlling Interest in Novo Healthnet

Ryan Allway

January 7th, 2015

News, Top News

Canadian Cannabis Corp. (“CCAN” or “The Company”) (CCAN), is pleased to announce that it has entered into a Letter of Intent (“LOI”) dated January 6, 2015 to acquire sixty-one percent (61%) of Novo HealthNet (“Novo”) in exchange for two million (2,000,000) common shares of The Company. The purchase shall be entirely paid through the issuance of CCAN common shares. The transaction represents an approximate 1.0 x revenue payment of 2,000,000 shares x $4.80 USD per share for a total of $9,600,000 United States Dollars (USD), approximately, $11,228,160 Canadian Dollars (CAD). The Company has engaged the audit firm BDO Canada to complete a review of the financials of Novo and has completed all other initial due diligence. The transaction is expected to close on February 12, 2015.

Novo has been successfully providing treatment solutions for patients as well as assessment and diagnostic services across Canada since 1996. Novo is the consolidation of Physiomed Peak, Peak Health, Back on Track and HealthNet Assessments Inc. Wholly-owned subsidiaries of Novo hold the following operating divisions:

  • Novo owns 14 multidisciplinary clinics and a network of 28 affiliate clinics and 3 partner clinics in the provinces of Ontario, Nova Scotia and Newfoundland;
  • Novo Peak Health Inc. operates Ontario Health Insurance Plan (OHIP), funds physiotherapy clinics, and serves the retirement and long term care homes of Physiomed Peak and Peak Health; and
  • Novo Assessments Inc. provides Independent medical evaluations for insurers, lawyers and employers.

Novo is a preferred provider within several insurance company networks. In 2013, Novo achieved its three-year re-accreditation for all its clinics through the North American standards of the Commission on Accreditation for Rehabilitation Facilities (CARF). Accreditation is a seal that ensures quality, safety and the best outcomes for its programs, services, and patients. Novo clinics are affiliated with the department of Physical Therapy at The University of Toronto and McMaster University for their residency programs.

The following table sets out a selection of relevant unaudited financial results for Novo and do not include any revenue from affiliate or partner clinics:

Year Ended August 30, 2014:

Revenue: $10,151,000.00 Canadian Dollars (CAD) approximately $8,737,305 United States Dollars (USD)

Year Ended August 30, 2013:

Revenue: $7,956,000 Canadian Dollars (CAD), approximately $6,847,995 United States Dollars (USD)

“The acquisition of a controlling interest in Novo Healthnet and its 45 clinics across the country provides shareholders of Canadian Cannabis Corp. with an established business and a stake in the third largest preferred provider network of multidisciplinary rehabilitation clinics in Canada,” said Canadian Cannabis Corp. CEO Benjamin Ward. “With an experienced management team, solid track record of value creation for its owner operators, and potential future downstream distribution capability for therapeutic Medicinal Marijuana, we are excited for the opportunity to move forward and integrate Novo, their CEO Kim Wei, and his team with our company.”

Canadian Cannabis Corp. has applied to Health Canada to become a producer of Medical Marijuana under the MMPR Legislation.

Cautionary Note Regarding Forward-Looking Statements

Safe Harbor:

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The “Act”). In particular, when used in the preceding discussion, the words “pleased,” “plan,” “confident that,” “believe,” “expect,” or “intend to,” and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, market conditions, competitive factors, the ability to successfully complete additional financings and other risks described in the Company’s SEC reports and filings.

About Canadian Cannabis Corporation:

Using an education and research focused platform targeted at healthcare providers and patients, Canadian Cannabis Corporation (CCC) will provide the highest quality medical marijuana to help manage a range of specific medical conditions and helps patients obtain their monthly prescription in a simple, seamless and transparent way. Where other Canadian marijuana growers are struggling with quality control and repeated recalls, CCC has the team and systems in place ensure the highest quality for its future patients. CCC is an innovator in the sector with globally recognized experts forming a core of its team including the first federally licensed grower in the United States.

http://canadiancannabiscorp.com/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading